Active engagement of conference participants is expected to discuss challenges and identify solutions on what could be done to optimise children’s access to new medicines:
- What data sources and digital technologies could bring to paediatric development on top of the use of extrapolation?
- How to best define children unmet medical needs?
- How to optimise the PIP process and regulatory approval
The conference will also explore what drug development means for Paediatricians, and in particular during COVID-19 pandemic.